The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF
1 other identifier
interventional
104
1 country
1
Brief Summary
Due to the complex nature of HF patients' conditions, long-term treatment and management are required, especially post hospital management, which is of great significance for improving patients' cardiac function and quality of life. With the increasing popularity of smartphones and the continuous development of medical technology, digital health intervention (DHI) has emerged as a new medical model in the treatment of diseases. This study will establish a comprehensive post hospital management model of HF based on DHI, including cognitive behavioral therapy, digital self-monitoring and remote dielectric sensing (ReDS™) technology, etc., comprehensively strengthen the post hospital intervention and management of HF. Objective to explore the effect of comprehensive post hospital management based on DHI on cardiac function of patients with HF 6 months after discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Apr 2025
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 21, 2025
CompletedFirst Posted
Study publicly available on registry
April 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2026
CompletedMarch 4, 2026
March 1, 2026
4 months
April 21, 2025
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-minute walk test
Improvement in 6-minute walk test after discharge for 6 months
The 6th month after discharge
Secondary Outcomes (9)
Quality of life index (QLI) rating
The 1st ,3rd and 6th months after discharge
Kansas city cardiomyopathy questionnaire (KCCQ-23) rating
The 1st ,3rd and 6th months after discharge
NYHA classification
The 1st ,3rd and 6th months after discharge
Left ventricular ejection fraction (LVEF)
The 6th month after discharge
Number of readmissions for heart failure
Within 6 months after discharge
- +4 more secondary outcomes
Study Arms (2)
Comprehensive post hospital management group
OTHERBased on the routine HF management of standard of care (SOC), the intervention group will carry out comprehensive post hospital management based on DHI, including cognitive behavioral therapy, digital self-monitoring and ReDS™ technology, etc.
Routine Management Group
NO INTERVENTIONThe routine management group will accept the routine HF management of SOC throughout the course, and the doctor will carry out treatment and management according to the actual clinical situation, including pre discharge education, precautions for commonly used drugs, guidance for daily life activities, etc.
Interventions
Based on the routine HF management of standard of care (SOC), the intervention group will carry out comprehensive post hospital management based on DHI, including cognitive behavioral therapy, digital self-monitoring and ReDS™ technology, etc.
Eligibility Criteria
You may qualify if:
- Patients hospitalized for HF, NYHA classification II-IV upon admission
- The patient's residence is within the urban area of each center, and ReDS™ technology can be performed at home or at the outpatient clinic
- No difficulty using smartphones, with basic Chinese reading and writing skills
- Accept the terms and conditions of the study and obtain informed consent from the subjects/their families
You may not qualify if:
- Age\<21 years old
- Patients with height\<155 cm or\>190 cm, BMI\<22 kg/m2 or\>36 kg/m2, chest circumference\<80 cm or\>115 cm, and flail chest or rib fractures
- History of pulmonary embolism
- chronic renal failure(Scr \> 443umol/L)
- History of heart transplantation or pacemaker implantation
- Severe pulmonary hypertension
- Suffering from end-stage chronic obstructive pulmonary disease, requiring home oxygen therapy
- Massive pleural effusion
- The subject is unable to complete the 6-minute walking test
- Expected lifespan\<6 months
- Researchers believe that participants are not suitable to participate in this trial (such as pregnancy, severe visual or hearing impairment, etc.)
- Individuals who are unable to understand and/or comply with this research procedure (such as those who are addicted to alcohol, substance abuse, or have mental illnesses)
- Currently participating in clinical trials of other devices or drugs
- Researchers involved in the design and execution of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, 150000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief Physician
Study Record Dates
First Submitted
April 21, 2025
First Posted
April 27, 2025
Study Start
April 1, 2025
Primary Completion
July 18, 2025
Study Completion
February 15, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03